<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-155193</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Therapy of the refractory ascites: Total paracentesis vs. TIPS</dc:title>
<dc:description xml:lang="en">This revision was aimed to report the evidences on the treatment of patients with cirrhosis and refractory ascites. Mainly, we wished to explore which of the predicting variables could be used to prefer large-volume paracentesis or TIPS (AU)</dc:description>
<dc:creator>Salerno, Francesco</dc:creator>
<dc:creator>La Mura, Vincenzo</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">Esta revisión tiene el objetivo de describir las pruebas del tratamiento de pacientes con cirrosis y ascitis refractaria. Se ha quedo explorar en especial cuáles son las variables predictivas para preferir una paracentesis de gran volumen o derivación portosistémica intrahepática transyugular (TIPS) (AU)</dc:description>
<dc:source>Gastroenterol Hepatol;39(7): 477-480, ago.-sept. 2016.</dc:source>
<dc:identifier>ibc-155193</dc:identifier>
<dc:title xml:lang="es">Tratamiento de la ascitis refractaria: paracentesis total frente a derivación portosistémica intrahepática transyugular</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d1208^s22009</dc:subject>
<dc:subject>^d33111^s22045</dc:subject>
<dc:subject>^d33093^s22045</dc:subject>
<dc:subject>^d8276^s22009</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:type>article</dc:type>
<dc:date>201609</dc:date>
</metadata>
</record>
</ibecs-document>
